Tags

Type your tag names separated by a space and hit enter

The medical management of reflux esophagitis. Role of antacids and acid inhibition.
Gastroenterol Clin North Am. 1990 Sep; 19(3):683-712.GC

Abstract

Of the more than 60 million adult Americans who have heartburn at least once a month, 60% choose over-the-counter medication rather than consulting their physician. Those individuals who do seek medical advice for reflux symptoms will probably receive a prescription for an H2-receptor antagonist, although in many instances simple life-style changes and occasional use of antacids may provide effective therapy. Patients who have severe esophagitis or reflux symptoms unresponsive to H2-receptor antagonists may be treated with a more potent antisecretory agent (proton pump inhibitor). The author discusses the role of antacids and acid inhibition in the treatment of gastroesophageal reflux disease. The results of the clinical trials with the H2-receptor antagonists, cimetidine, ranitidine, famotidine, and nizatidine, and the proton pump inhibitor omeprazole, are compared and contrasted.

Authors+Show Affiliations

Department of Ambulatory Care, VA Hospital, Hines, Illinois.

Pub Type(s)

Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial
Review

Language

eng

PubMed ID

1977703

Citation

Sontag, S J.. "The Medical Management of Reflux Esophagitis. Role of Antacids and Acid Inhibition." Gastroenterology Clinics of North America, vol. 19, no. 3, 1990, pp. 683-712.
Sontag SJ. The medical management of reflux esophagitis. Role of antacids and acid inhibition. Gastroenterol Clin North Am. 1990;19(3):683-712.
Sontag, S. J. (1990). The medical management of reflux esophagitis. Role of antacids and acid inhibition. Gastroenterology Clinics of North America, 19(3), 683-712.
Sontag SJ. The Medical Management of Reflux Esophagitis. Role of Antacids and Acid Inhibition. Gastroenterol Clin North Am. 1990;19(3):683-712. PubMed PMID: 1977703.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The medical management of reflux esophagitis. Role of antacids and acid inhibition. A1 - Sontag,S J, PY - 1990/9/1/pubmed PY - 1990/9/1/medline PY - 1990/9/1/entrez SP - 683 EP - 712 JF - Gastroenterology clinics of North America JO - Gastroenterol. Clin. North Am. VL - 19 IS - 3 N2 - Of the more than 60 million adult Americans who have heartburn at least once a month, 60% choose over-the-counter medication rather than consulting their physician. Those individuals who do seek medical advice for reflux symptoms will probably receive a prescription for an H2-receptor antagonist, although in many instances simple life-style changes and occasional use of antacids may provide effective therapy. Patients who have severe esophagitis or reflux symptoms unresponsive to H2-receptor antagonists may be treated with a more potent antisecretory agent (proton pump inhibitor). The author discusses the role of antacids and acid inhibition in the treatment of gastroesophageal reflux disease. The results of the clinical trials with the H2-receptor antagonists, cimetidine, ranitidine, famotidine, and nizatidine, and the proton pump inhibitor omeprazole, are compared and contrasted. SN - 0889-8553 UR - https://www.unboundmedicine.com/medline/citation/1977703/The_medical_management_of_reflux_esophagitis__Role_of_antacids_and_acid_inhibition_ L2 - https://medlineplus.gov/gerd.html DB - PRIME DP - Unbound Medicine ER -